Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART outcomes in women with adenomyosis by stimulation protocol and immuno-endometrial features
2024-516089-12-00Phase 4Authorised
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Aug 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of leuprolide and dienogest in female infertility and adenomyosis (2 arms), sponsored by Azienda Ospedaliera Universitaria Policlinico. Primary endpoint: Association of adenomyosis with fertility outcomes by COH protocol. Planned start Aug 2024; status: authorised.
02
Drugs
leuprolidedienogest
03
Conditions
female infertilityadenomyosis
Beyond the preview
Go deeper on 2024-516089-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516089-12-00.